No Priors: Artificial Intelligence | Technology | Startups
AI-Powered Biological Software with Jakob Uszkoreit, CEO of Inceptive
Aug 24, 2023
Jakob Uszkoreit, CEO and Co-founder of Inceptive, is a deep learning pioneer who previously co-authored the game-changing paper 'Attention is All You Need' at Google. In this conversation, he delves into the future of biological software and its pivotal role in optimizing mRNA therapies and vaccine production. He highlights the innovative intersection of deep learning and biology, discussing challenges in drug discovery and the promise of simpler model architectures driven by hardware advancements. Collaborations at Inceptive showcase the exciting frontier of biotechnological research.
35:23
Episode guests
AI Summary
Highlights
AI Chapters
Episode notes
Podcast summary created with Snipd AI
Quick takeaways
- Inceptive is using deep learning to design RNA and mRNA molecules for more efficient drug production and distribution in the field of medicine.
- The application of deep learning to biology enables the design of complex RNA-based medicines with personalized functions and scalability advantages for future medical interventions.
Deep dives
Inceptive's Focus on Biological Software
Inceptive, a company founded by Jakub Uskarit, aims to design better RNA and mRNA molecules for various medicines. The goal is to use deep learning models to translate biological programs into RNA molecule descriptions that can perform specific functions in the body. This approach allows for the creation of complex and scalable medicines that can be manufactured and distributed more efficiently than traditional protein-based biologics. Inceptive believes that deep learning, with its ability to work with black box systems, could revolutionize the field of biology and lead to significant advancements in medicine.
Remember Everything You Learn from Podcasts
Save insights instantly, chat with episodes, and build lasting knowledge - all powered by AI.
